EU approves remdesivir for COVID-19 treatment
Published
The use of the medication remdesivir to treat severe cases of COVID-19 in the European Union has been approved by the European Commission.
Full ArticlePublished
The use of the medication remdesivir to treat severe cases of COVID-19 in the European Union has been approved by the European Commission.
Full ArticleThe European Commission has signed a contract with the pharmaceutical company Gilead to secure treatment doses of Veklury, the..
Humanigen Inc (OTCQB:HGEN) said Monday that its lead drug candidate lenzilumab was selected for use in the National Institute of..